Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Erectile DysfunctionPhosphodiesterase 5 Inhibitor
Interventions
DRUG

Udenafil

Udenafil tablets

DRUG

Placebo

Placebo tablets

Trial Locations (1)

Unknown

Querétaro

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01967264 - Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults | Biotech Hunter | Biotech Hunter